Tenderwize
Back to tender search

Medicinal products for gene therapies

Dirección General de Recursos Económicos del Servicio Canario de la Salud·Las Palmas de Gran Canaria, Spain·EUR 65.8M·Deadline Apr 17, 2031 · 1758 days left·Restricted·Supplies·DPS
High valueStructured notice only
Original notice title

Suministro de medicamentos destinado a terapias genicas mediante SDA

60/100

Opportunity Score

PromisingMedium complexity
SuppliesDPSOpen
Why this score?

Opportunity

60 / 100

Complexity

55 / 100

Risk factors

Selection criteria require annual turnover and references; not meeting thresholds could disqualify.

DPS may have many competitions; each may require separate submission with short deadlines.

Restricted procedure — pre-qualification required

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • EUR 65.8M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 2 lots
  • Duration until Apr 2031
  • Supply of advanced gene therapy medicinal products for spinal muscular atrophy and hemophilia B.
  • Destined for patients of the Canary Health Service (Servicio Canario de la Salud).
Show full summary

This tender is for a Dynamic Purchasing System (DPS) for the supply of advanced gene therapy medicines for spinal muscular atrophy (SMA) and hemophilia B to patients of the Canary Health Service. The DPS is divided into two lots with a total estimated value of €65,765,376. The procedure is restricted, award is based solely on price (100% weight), and submissions are electronic in Spanish. Tenderers may only bid for one lot.

Risks

Selection criteria require annual turnover and references; not meeting thresholds could disqualify.

DPS may have many competitions; each may require separate submission with short deadlines.

Restricted procedure — pre-qualification required

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Restricted procedure: only invited candidates may submit tenders.
  • Electronic submission is required.
  • All documents must be in Spanish.

Requirements may be incomplete.

Award Criteria

Lot 1

precio. . Precio100%

Lot 2

precio. . Price100%

Buyer

Name

Dirección General de Recursos Económicos del Servicio Canario de la Salud

Location

Las Palmas de Gran Canaria, ESP

Buyer profile

Open profile

Identifier

21058580149618

Lots (2)

LOT-0001

Terapia génica para la atrofia muscular espinal

Supply of gene therapy for spinal muscular atrophy (SMA).

SuppliesDPSEU fundedElectronic submission

EUR 24.7M

Estimated value

Location

ES709, Spain

Duration

Apr 2026 - Apr 2031

Category

Medicinal products

Selection criteria

Price

LOT-0002

Terapia génica para la hemofilia B

Supply of gene therapy for hemophilia B.

SuppliesDPSEU fundedElectronic submission

EUR 30.1M

Estimated value

Location

ES709, Spain

Duration

Apr 2026 - Apr 2031

Category

Medicinal products

Selection criteria

Price

Procurement Details

Publication date
19 Apr 2026
Notice type
Contract notice — standard
Languages
Spanish

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
267052-2026
Source notice ID
1fb71b04-28e1-4636-be93-e2a45cf847d0

Documents (1)

Similar tenders